Crossmark

Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome

Crossref DOI link: https://doi.org/10.1186/s12967-020-02314-y

Published Online: 2020-04-01

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yue

Ding, Xiaosong

Hua, Bing

Liu, Qingbo

Chen, Hui

Zhao, Xue-Qiao

Li, Weiping

Li, Hongwei https://orcid.org/0000-0001-5900-7088
Funding

Funding for this research was provided by:

the National Natural Science Foundation of China (Grant No. 81670315)

the Natural Science Foundation of Beijing (Grant No. 7172059)
License Information

Text and Data Mining valid from 2020-04-01

Version of Record valid from 2020-04-01
More Information

Article History

Received: 13 February 2020

Accepted: 23 March 2020

First Online: 1 April 2020

Ethics approval and consent to participate

: The study data collections were approved by the Institutional Review Board of Beijing Friendship Hospital affiliated to Capital Medical University, and written informed consent was obtained from all patients.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below